News

Celeris Therapeutics Welcomes Life Sciences and Technology Thought Leader Ian Marks as a Non-Executive Director

EINPresswire – August 27, 2021

Global VP of Life Sciences at Salesforce contributes a great deal of experience in life sciences, pharma and technology

Rational design for protein degradation? Austrian deep learning startup takes a stab

Endpoints – July 19, 2021

Rational design for protein degradation? Austrian deep learning startup takes a stab

600.000 Euro für Grazer Startup Celeris

Der Brutkasten – May 3, 2021

Knapp nach einem 400.000 Euro Seed-Investment holt sich Celeris aus Graz eine aws-Förderung für seine Medikamentenforschungstechnologie.

Cutting longevity drugs development from 15 years to on

Noah Weber – March 31, 2021

Celeris bags €400k for creation of deep learning platform to support development of longevity drugs for Alzheimer’s and other age-related diseases.

Accelerating drug discovery through artificial intelligence would help to bring longevity innovations to the clinic more quickly.

Lifespan.io – April 06, 2021

We all know that technology is rapidly improving and changing how we live. But we’re going to need even more technological breakthroughs to improve human maximum healthspan and lifespan. Can a new start-up cut longevity drugs development from 15 years to one?

Grazer Biotech-Startup erhält 400.000 Euro Pre-Seed-Investment

Der Brutkasten – March 31, 2021

Celeris Therapeutics will mit seiner Plattform ermöglichen, dass bessere Medikamente schneller auf den Markt kommen – und konnte damit internationale Investoren überzeugen.

Durch künstliche Intelligenz zum perfekten Medikament

CHEManager – January 26, 2021

Eine Deep-Learning-Plattform für medizinische Chemiker zur schnelleren und genaueren Vorhersage von Bindungsaffinitäten und daraus resultierendem Design von Arzneimitteln – das will das Start-up Celeris Therapeutics aus Graz noch dieses Jahr zur Marktreife entwickeln.